Time Mat(t)ers: A study to evaluate shared care for cancer patients in follow up care for specific patient cohorts, currently including Colorectal and prostate cancer.

The aim of this project is to integrate shared care models into CMN outpatient cancer services, improving access for new cancer patients and delivery of outpatient follow up care (including patient communication) to all patients. the study will make an assessment of feasibility, application, acceptability and effectiveness of the shared model of care. The study is a feasibility evaluation using mixed-methods research. The components are: •Quantitative: Health service data of all patient participants engaged in the intervention groups and communication between cancer service and GPs. Patient reported outcome and experience measures will be collected throughout the feasibility evaluation (baseline, 6 months, 12 months). •Qualitative: Patient Participant interviews, GP, CMN cancer service staff survey and patient experience survey collected at the conclusion of the feasibility evaluation The project will commence with two patient cohorts with others added over time: 1. receiving post active (follow-up) care for colorectal cancer, Participants will attend their planned appointments per their shared care plan that will be provided to them by their treating specialists (Medical or Radiation Oncologist). in the first 12 months of follow up patients will attend 3 monthly follow up appointments that alternate between the treating team (Medical oncologist, surgeon) and their GP for patients with colon cancer and for patients with rectal cancer appointments with the treating team (medical and radiation oncologists and surgeon) and their GP, Appointments are generally face to face. or 2. receiving ongoing surveillance of androgen deprivation therapy (ADT) for prostate cancer Participants will attend their planned appointments per their personalised shared care plan that will be provided to them by their treating specialists (Medical or Radiation Oncologist). Participants will complete patient reported outcomes questionnaires at baseline, 6 and 12 months and the patient reported experience questionnaire at 12 months. Note there is no prescribed shared care schedule for prostate cancer patients receiving androgen deprivation therapy as the shared care plan is individualised by the treating clinician for each individual patient this includes follow up schedule with GP and any required PSA blood tests. All patients and GPs will be provided with a shared care schedule and follow up data collection via GP will be performed to ensure adherence to the schedule. Variation from the model included missed/delayed appointments, including 3 months or more from the scheduled appointment for scan or appointment with Specialist team or GP and /or 2 months for tumour markers will speak to the feasibility of shared care model.